{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:46:40Z","timestamp":1792036000808,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rcsop.2026.100831","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:43:11Z","timestamp":1786722191000},"page":"100831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Medication adherence in epilepsy: Validation of the short medication adherence scale (SMAS-7) and mediation analysis of quality-of-life pathways"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5191-3497","authenticated-orcid":false,"given":"Mariam","family":"Dabbous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6905-5814","authenticated-orcid":false,"given":"Fouad","family":"Sakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4780-0772","authenticated-orcid":false,"given":"Pascale","family":"Salameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2171-2977","authenticated-orcid":false,"given":"Pierre-Marie","family":"Preux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rcsop.2026.100831_bb0005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"23","year":"2024","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100831_bb0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.rcsop.2026.100831_bb0015","doi-asserted-by":"crossref","first-page":"18024","DOI":"10.1038\/nrdp.2018.24","article-title":"Epilepsy","volume":"4","author":"Devinsky","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.rcsop.2026.100831_bb0020","article-title":"Psychological treatments for people with epilepsy","volume":"10","author":"Michaelis","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.rcsop.2026.100831_bb0025","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s10072-017-3075-6","article-title":"Affective symptoms and determinants of health-related quality of life in Mexican people with epilepsy","volume":"38","author":"Camara-Lemarroy","year":"2017","journal-title":"Neurol Sci"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100831_bb0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ncl.2015.11.002","article-title":"Assessment of treatment side effects and quality of life in people with epilepsy","volume":"34","author":"Blond","year":"2016","journal-title":"Neurol Clin"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100831_bb0035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1474-4422(15)00225-2","article-title":"Comorbidities of epilepsy: current concepts and future perspectives","volume":"15","author":"Keezer","year":"2016","journal-title":"Lancet Neurol"},{"issue":"suppl 4","key":"10.1016\/j.rcsop.2026.100831_bb0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/epi.12298","article-title":"Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy","volume":"54","author":"Brooks-Kayal","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100831_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ncl.2015.08.008","article-title":"Treatment of cognitive deficits in epilepsy","volume":"34","author":"Leeman-Markowski","year":"2016","journal-title":"Neurol Clin"},{"issue":"7","key":"10.1016\/j.rcsop.2026.100831_bb0050","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.healthpol.2018.05.012","article-title":"Changing the neurology policy landscape in the United States: misconceptions and facts about epilepsy","volume":"122","author":"Grabowski","year":"2018","journal-title":"Health Policy"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100831_bb0055","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/ane.12703","article-title":"A review of medication adherence in people with epilepsy","volume":"135","author":"Malek","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.rcsop.2026.100831_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2016.02.001","article-title":"Treatment non-adherence in pseudo-refractory epilepsy","volume":"122","author":"Brodtkorb","year":"2016","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100831_bb0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5603\/PJNNS.a2019.0008","article-title":"Health-related quality of life and medication adherence in elderly patients with epilepsy","volume":"53","author":"Hamedi-Shahraki","year":"2019","journal-title":"Neurol Neurochir Pol"},{"issue":"6","key":"10.1016\/j.rcsop.2026.100831_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.71550","article-title":"Factors associated with antiseizure medication adherence in patients with epilepsy: a systematic review","volume":"16","author":"Turan","year":"2026","journal-title":"Brain Behav"},{"key":"10.1016\/j.rcsop.2026.100831_bb0075","article-title":"The short medication adherence scale (SMAS-7): development and psychometric validation in a general population sample","volume":"20","author":"Sakr","year":"2025","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"7","key":"10.1016\/j.rcsop.2026.100831_bb0080","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/epi.14444","article-title":"Psychological treatments for adults and children with epilepsy: evidence-based recommendations by the international league against epilepsy psychology task force","volume":"59","author":"Michaelis","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.rcsop.2026.100831_bb0085","article-title":"The 6-item InCharge financial distress\/financial wellbeing (IFDFW-6) scale: development and validation in pharmacy and epidemiology research","volume":"22","author":"Sakr","year":"2026","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"8","key":"10.1016\/j.rcsop.2026.100831_bb0090","article-title":"Adherence to post-stroke pharmacotherapy: scale validation and correlates among a sample of stroke survivors","volume":"58","author":"Sakr","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.rcsop.2026.100831_bb0095","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3934296","article-title":"A new Lebanese medication adherence scale: validation in Lebanese hypertensive adults","volume":"2018","author":"Bou Serhal","year":"2018","journal-title":"Int J Hypertens"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100831_bb0100","doi-asserted-by":"crossref","DOI":"10.4103\/nsn.nsn_83_23","article-title":"The Liverpool adverse drug events profile (LAEP): validity and reliability of Turkish version (LAEP-TR)","volume":"40","author":"Dibek","year":"2023","journal-title":"Neurol Sci Neurophysiol"},{"key":"10.1016\/j.rcsop.2026.100831_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107309","article-title":"Validation of the Serbian version of the Liverpool adverse events profile of antiseizure therapy in patients with epilepsy","volume":"111","author":"Soki\u0107","year":"2020","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100831_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-46379-z","article-title":"Development, psychometric validation, and correlates of the 15-item quality of life in epilepsy scale (QOLIE-15)","volume":"16","author":"Dabbous","year":"2026","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100831_bb0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/seiz.2002.0672","article-title":"The A-B neuropsychological assessment schedule (ABNAS): the relationship between patient-perceived drug related cognitive impairment and results of neuropsychological tests","volume":"11","author":"Aldenkamp","year":"2002","journal-title":"Seizure"},{"key":"10.1016\/j.rcsop.2026.100831_bb0120","series-title":"Development and Psychometric Validation of the Mental Health Assessment in Epilepsy Scale (MHAIE-11): A Multidimensional Measure","author":"Dabbous","year":"2026"},{"key":"10.1016\/j.rcsop.2026.100831_bb0125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fpubh.2018.00149","article-title":"Best practices for developing and validating scales for health, social, and behavioral research: a primer","volume":"6","author":"Boateng","year":"2018","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100831_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10705519909540118","article-title":"Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives","volume":"6","author":"Hu","year":"1999","journal-title":"Struct Equ Model Multidiscip J"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100831_bb0135","first-page":"23","article-title":"Evaluating the fit of structural equation models: tests of significance and descriptive goodness-of-fit measures","volume":"8","author":"Schermelleh-Engel","year":"2003","journal-title":"Methods Psychol Res Online"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100831_bb0140","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/10705510701301834","article-title":"Sensitivity of goodness of fit indexes to lack of measurement invariance","volume":"14","author":"Chen","year":"2007","journal-title":"Struct Equ Model Multidiscip J"},{"key":"10.1016\/j.rcsop.2026.100831_bb0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.dr.2016.06.004","article-title":"Measurement invariance conventions and reporting: the state of the art and future directions for psychological research","volume":"41","author":"Putnick","year":"2016","journal-title":"Dev Rev"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100831_bb0150","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/10705511.2010.489379","article-title":"Power analysis for complex mediational designs using Monte Carlo methods","volume":"17","author":"Thoemmes","year":"2010","journal-title":"Struct Equ Model Multidiscip J"},{"issue":"12","key":"10.1016\/j.rcsop.2026.100831_bb0155","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1528-1167.2011.03213.x","article-title":"Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review","volume":"52","author":"Taylor","year":"2011","journal-title":"Epilepsia"},{"issue":"suppl 6","key":"10.1016\/j.rcsop.2026.100831_bb0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1528-1157.43.s.6.12.x","article-title":"The psychosocial burden of epilepsy","volume":"43","author":"Baker","year":"2002","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100831_bb0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/nedt.2007.3.1.117","article-title":"Managing patient adherence and quality of life in epilepsy","volume":"3","author":"Eatock","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100831_bb0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.yebeh.2012.08.027","article-title":"Adherence to antiepilepsy drug therapy","volume":"25","author":"Faught","year":"2012","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100831_bb0175","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1586\/14737167.7.4.373","article-title":"Patient-reported outcomes measurements in epilepsy","volume":"7","author":"Stafford","year":"2007","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100831_bb0180","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1528-1157.1997.tb01128.x","article-title":"Quality of life of people with epilepsy: a European study","volume":"38","author":"Baker","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.rcsop.2026.100831_bb0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.yebeh.2015.01.034","article-title":"Psychosocial factors associated with medication adherence in ethnically and socioeconomically diverse patients with epilepsy","volume":"46","author":"Shallcross","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100831_bb0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13561-022-00369-9","article-title":"Cardiovascular drug shortages in Lebanon: a broken heart","volume":"12","author":"Khattar","year":"2022","journal-title":"Health Econ Rev"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100831_bb0195","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/01.WNL.0000103282.62353.85","article-title":"Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy","volume":"62","author":"Boylan","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.rcsop.2026.100831_bb0200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yebeh.2005.05.014","article-title":"Anxiety in patients with epilepsy: systematic review and suggestions for clinical management","volume":"7","author":"Beyenburg","year":"2005","journal-title":"Epilepsy Behav"},{"issue":"11","key":"10.1016\/j.rcsop.2026.100831_bb0205","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s00415-019-09503-w","article-title":"Self-management practices associated with quality of life for adults with epilepsy","volume":"266","author":"Quon","year":"2019","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100831_bb0210","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.yebeh.2011.08.022","article-title":"Determinants of quality of life in people with epilepsy and their gender differences","volume":"22","author":"Yue","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.rcsop.2026.100831_bb0215","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.yebeh.2015.06.035","article-title":"Subjective cognitive complaints versus objective neuropsychological performance in older adults with epilepsy","volume":"51","author":"Galioto","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"2\u20133","key":"10.1016\/j.rcsop.2026.100831_bb0220","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.eplepsyres.2009.02.006","article-title":"Subjective complaints compared to the results of neuropsychological assessment in patients with epilepsy: the influence of comorbid depression","volume":"84","author":"Liik","year":"2009","journal-title":"Epilepsy Res"},{"issue":"10","key":"10.1016\/j.rcsop.2026.100831_bb0225","article-title":"Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy","volume":"10","author":"Al-Aqeel","year":"2020","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276626001290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276626001290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:08:28Z","timestamp":1792033708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276626001290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":45,"alternative-id":["S2667276626001290"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2026.100831","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication adherence in epilepsy: Validation of the short medication adherence scale (SMAS-7) and mediation analysis of quality-of-life pathways","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2026.100831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100831"}}